Stefan K. Grebe

9.2k total citations · 1 hit paper
86 papers, 6.1k citations indexed

About

Stefan K. Grebe is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Stefan K. Grebe has authored 86 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Molecular Biology and 14 papers in Surgery. Recurrent topics in Stefan K. Grebe's work include Thyroid Cancer Diagnosis and Treatment (24 papers), Thyroid Disorders and Treatments (10 papers) and Adrenal and Paraganglionic Tumors (9 papers). Stefan K. Grebe is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (24 papers), Thyroid Disorders and Treatments (10 papers) and Adrenal and Paraganglionic Tumors (9 papers). Stefan K. Grebe collaborates with scholars based in United States, New Zealand and United Kingdom. Stefan K. Grebe's co-authors include Ravinder J. Singh, Ian Hay, William F. Young, Jacques W.M. Lenders, Graeme Eisenhofer, Anne‐Paule Gimenez‐Roqueplo, M. Hassan Murad, Mitsuhide Naruse, Quan‐Yang Duh and Karel Pacák and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Stefan K. Grebe

85 papers receiving 6.0k citations

Hit Papers

Pheochromocytoma and Paraganglioma: An Endocrine Society ... 2014 2026 2018 2022 2014 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan K. Grebe United States 38 3.6k 2.5k 1.2k 1.1k 774 86 6.1k
Ernst J. Schaefer United States 51 3.2k 0.9× 4.3k 1.7× 1.4k 1.2× 1.8k 1.6× 142 0.2× 109 7.7k
Eleni Bairaktari Greece 36 1.1k 0.3× 1.4k 0.6× 501 0.4× 946 0.9× 258 0.3× 146 3.9k
Heinrich Wieland Germany 37 1.6k 0.4× 1.9k 0.8× 675 0.6× 1.0k 0.9× 137 0.2× 144 5.1k
Adam Krętowski Poland 37 1.1k 0.3× 861 0.4× 513 0.4× 1.7k 1.6× 250 0.3× 336 5.5k
Ralf Dechend Germany 61 2.0k 0.6× 1.5k 0.6× 668 0.6× 2.3k 2.0× 478 0.6× 269 12.5k
James W. Scholey Canada 46 2.2k 0.6× 792 0.3× 287 0.2× 2.1k 1.9× 640 0.8× 135 8.3k
Paul G. Walfish Canada 44 3.2k 0.9× 1.6k 0.6× 222 0.2× 1.1k 1.0× 840 1.1× 160 6.2k
Berthold Hocher Germany 53 1.6k 0.4× 1.1k 0.5× 296 0.3× 2.2k 2.0× 886 1.1× 355 9.4k
Clive R. Pullinger United States 40 1.5k 0.4× 2.2k 0.9× 783 0.7× 1.7k 1.6× 137 0.2× 122 6.0k
J.J. Emeis Netherlands 42 1.7k 0.5× 1.5k 0.6× 806 0.7× 1.2k 1.1× 226 0.3× 112 7.4k

Countries citing papers authored by Stefan K. Grebe

Since Specialization
Citations

This map shows the geographic impact of Stefan K. Grebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan K. Grebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan K. Grebe more than expected).

Fields of papers citing papers by Stefan K. Grebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan K. Grebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan K. Grebe. The network helps show where Stefan K. Grebe may publish in the future.

Co-authorship network of co-authors of Stefan K. Grebe

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan K. Grebe. A scholar is included among the top collaborators of Stefan K. Grebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan K. Grebe. Stefan K. Grebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faber, Jennifer, et al.. (2023). Overcoming the chromatographic challenges when performing LC-MS/MS measurements of pyridoxal-5′-phosphate. Journal of Chromatography B. 1217. 123605–123605. 1 indexed citations
2.
Oliveira, Jennifer L., Lori Frederick, Mrinal M. Patnaik, et al.. (2018). Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience. American Journal of Hematology. 93(8). 1029–1041. 33 indexed citations
3.
Grebe, Stefan K., et al.. (2018). Compound heterozygosity for a whole gene deletion and p.R124C mutation in CYP21A2 causing nonclassic congenital adrenal hyperplasia. Annals of Pediatric Endocrinology & Metabolism. 23(3). 158–161. 1 indexed citations
4.
Bancos, Irina, et al.. (2017). High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders. Clinical Chemistry. 63(12). 1824–1835. 68 indexed citations
6.
Ketha, Hemamalini, Ravinder J. Singh, Stefan K. Grebe, et al.. (2015). Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers. PLoS ONE. 10(9). e0137350–e0137350. 32 indexed citations
7.
Roemeling, Christina A. Von, Derek C. Radisky, Laura A. Marlow, et al.. (2014). Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4. Cancer Research. 74(17). 4796–4810. 156 indexed citations
8.
Ketha, Hemamalini, Sukhbir Kaur, Stefan K. Grebe, & Ravinder J. Singh. (2014). Clinical applications of LC-MS sex steroid assays. Current Opinion in Endocrinology Diabetes and Obesity. 21(3). 217–226. 50 indexed citations
9.
Algeciras‐Schimnich, Alicia, David E. Bruns, James C. Boyd, et al.. (2013). Failure of Current Laboratory Protocols to Detect Lot-to-Lot Reagent Differences: Findings and Possible Solutions. Clinical Chemistry. 59(8). 1187–1194. 78 indexed citations
10.
Grebe, Stefan K.. (2013). Soluble thyroid tumor markers - old and new challenges and potential solutions. 67(3). 76. 2 indexed citations
11.
Cooper, Simon, Christina A. Von Roemeling, Laura A. Marlow, et al.. (2012). Reexpression of Tumor Suppressor, sFRP1, Leads to Antitumor Synergy of Combined HDAC and Methyltransferase Inhibitors in Chemoresistant Cancers. Molecular Cancer Therapeutics. 11(10). 2105–2115. 52 indexed citations
12.
Grebe, Stefan K. & George J. Kahaly. (2012). Laboratory Testing in Hyperthyroidism. The American Journal of Medicine. 125(9). S2–S2. 9 indexed citations
13.
Hackbarth, Jennifer S., Jonathan Hoyne, Stefan K. Grebe, & Ravinder Singh. (2010). Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration. Steroids. 76(1-2). 48–55. 42 indexed citations
14.
Eberhardt, Norman L., Stefan K. Grebe, Bryan McIver, & Honey V. Reddi. (2009). The role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancer. Molecular and Cellular Endocrinology. 321(1). 50–56. 72 indexed citations
15.
Algeciras‐Schimnich, Alicia, Carol M. Preissner, William F. Young, Ravinder J. Singh, & Stefan K. Grebe. (2007). Plasma Chromogranin A or Urine Fractionated Metanephrines Follow-Up Testing Improves the Diagnostic Accuracy of Plasma Fractionated Metanephrines for Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 93(1). 91–95. 73 indexed citations
16.
Şahi̇n, Mustafa, Shaohua Wang, Ian Hay, et al.. (2004). The PAX8/PPARγ fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARγ inhibition. Oncogene. 23(20). 3634–3641. 79 indexed citations
17.
Preissner, Carol M., Dennis J. O’Kane, Ravinder Singh, John C. Morris, & Stefan K. Grebe. (2003). Phantoms in the Assay Tube: Heterophile Antibody Interferences in Serum Thyroglobulin Assays. The Journal of Clinical Endocrinology & Metabolism. 88(7). 3069–3074. 134 indexed citations
18.
Velickovic, Marija, Brett Delahunt, Bryan McIver, & Stefan K. Grebe. (2002). Intragenic PTEN/MMAC1 Loss of Heterozygosity in Conventional (Clear-Cell) Renal Cell Carcinoma is Associated with Poor Patient Prognosis. Modern Pathology. 15(5). 479–485. 59 indexed citations
19.
Grebe, Stefan K., et al.. (1997). Inhaled beclomethasone dipropionate suppresses the hypothalamo–pituitary–adrenal axis in a dose dependent manner. Clinical Endocrinology. 47(3). 297–304. 21 indexed citations
20.
Grebe, Stefan K., John DeLaHunt, Colin M. Feek, Gordon Purdie, & David Porter. (1995). Lack of evidence for pituitary thyrotroph down-regulation after 1 week of oral thyrotrophin-releasing hormone and metoclopramide under conditions of constant peripheral thyroid hormone levels. European Journal of Endocrinology. 132(3). 331–337. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026